Klinische Studien Nct Page
Clinical Trial Results:
Randomized Phase II Study of Amrubicin as Single Agent or in Combination with Cisplatin versus Etoposide-Cisplatin as first-Line Treatment in Patients with Extensive Stage SCLC
| Summary | |
EudraCT number | 2006-001956-11 |
Trial protocol | BE GB IT NL |
Global completion date | 07 Sep 2010 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 11 May 2016 |
First version publication date | 11 May 2016 |
Other versions | |
Summary report(s) | CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.